PTSM: Pharmaceutical Technology Sourcing and Management, Jun 5, 2013 - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

PTSM: Pharmaceutical Technology Sourcing and Management, Jun 5, 2013
Global Feature
A Pharma Industry Mid-Year Review and Outlook
By Patricia Van Arnum
Emerging markets remain strong as established markets fare less well.
APIs
Innovation in Sourcing and Procurement
By Patricia Van Arnum
The upcoming DCAT Sharp Sourcing 2013 conference addresses the challenges and opportunities in pharmaceutical sourcing and procurement.
Outsourcing
Outsourcing's Modest Role as a Cost-Containment Strategy
By Eric Langer
Outsourcing is weighing in more as a tactic for cost-cutting, but it is still not the primary weapon.
Pharma Partner Focus
Aesica in an Expansion Mode
By Patricia Van Arnum
The CMO Aesica has used a combination of organic growth and acquisitions to build its business and is seeking to expand its geographic footprint.
CSR and Sustainability Forum
Pharma News in Global Health and Sustainability
A roundup of developments in global health and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations.
Pharma Industry Participates in Global Health Initiatives
By Patricia Van Arnum
Highlights from the 66th World Health Assembly and the pharmaceutical industry?s role in addressing noncommunicable diseases, mental and neurological disorders, R&D for diseases of the developing world, counterfeit medicines, the global vaccine action plan, and neglected tropical diseases.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
26%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
32%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here